摘要
Glioblastoma multiforme (GBM) is the most common and malignant brain tumor with poor prognosis. The heterogeneous and aggressive nature of GBMs increases the difficulty of current standard treatment. The presence of GBM stem cells and the blood brain barrier (BBB) further contribute to the most important compromise of chemotherapy and radiation therapy. Current suggestions to optimize GBM patients’ outcomes favor controlled targeted delivery of chemotherapeutic agents to GBM cells through the BBB using nanoparticles and monoclonal antibodies. Nanotechnology and nanocarrier-based drug delivery have recently gained attention due to the characteristics of biosafety, sustained drug release, increased solubility, and enhanced drug bioactivity and BBB penetrability. In this review, we focused on recently developed nanoparticles and emerging strategies using nanocarriers for the treatment of GBMs. Current studies using nanoparticles or nanocarrier-based drug delivery system for treatment of GBMs in clinical trials, as well as the advantages and limitations, were also reviewed.
原文 | 英語 |
---|---|
文章編號 | 195 |
頁(從 - 到) | 1-22 |
頁數 | 22 |
期刊 | Cancers |
卷 | 13 |
發行號 | 2 |
DOIs | |
出版狀態 | 已出版 - 02 01 2021 |
文獻附註
Publisher Copyright:© 2021 by the authors. Licensee MDPI, Basel, Switzerland.